Genetic Mutation Increases Risk of Parkinson’s Disease From Pesticides
Mutations in the alpha-synuclein gene can cause increased vulnerability to pesticides, which may lead to Parkinson’s disease.
Breaking the Brain Clock Predisposes Nerve Cells to Neurodegeneration
Researchers discover the expression of certain clock genes plays a critical role in delaying the emergence of age-related signs in the brain.
Gene-Silencing Study Finds New Targets for Parkinson’s Disease
Researchers use RNAi to reveal dozens of genes which could represent new therapeutic targets for treating Parkinson’s disease.
New Study Identifies Genes Uniquely Expressed by the Brain’s Immune Cells
Researchers use a novel sequencing method to identify a group of genes used by microglia to sense pathogenic organisms, toxins and damaged neurons.
Symptoms of Parkinson’s Disease Linked to Fungus
Researchers have discovered a volatile organic compound, 1-octen-3-ol, which is often emitted by mold, could be linked to the symptoms of Parkinson’s disease.
Absence of the SMG1 Protein Could Contribute to Parkinson’s and Other Neurological Disorders
A new study links a lack of SMG1 to protein aggregates associated with Parkinson’s disease and other neurodegenerative diseases.
Rare Childhood Disease May Hold Clues to Treating Alzheimer’s and Parkinson’s
Researchers studying the cause of A-T disease believe their findings could provide new clues to understanding neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.
Lou Gehrig’s Disease: From Patient Stem Cells to Potential Treatment Strategy in One Study
Researchers create neurons from the skin cells of ALS patients in order to “treat” a gene defect in a dish.
Brainpower Applied to Understanding of Neural Stem Cells
Researchers discover SMEK1 promotes the differentiation of neural stem and progenitor cells while, at the same time, keeping these cells in check by suppressing their uncontrolled proliferation.
Yeast, Human Stem Cells Drive Discovery of New Parkinson’s Disease Drug Targets
Researchers have identified a novel Parkinson’s disease drug target and a compound capable of repairing neurons derived from Parkinson’s patients.
